TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Public Interest Representatives Says Clearinghouse Delayed TRIS Action; Brown Refutes Charge March 10, 1978
TCL Archive Brooks Wins ACS Award. NCI Would Get $4.725 Billion, 12% Increase, In Bush Budget. February 8, 2002
